Erin Clancy

2 weeks ago | pulmonologyadvisor.com | Erin Clancy

Researchers and institutions that rely on funding from the National Institutes of Health (NIH) are contending with ongoing efforts by the Trump administration to cut NIH funding, terminate research grants, and reduce the agency’s workforce.1-31 “From what I understand, the environment within NIH is very stressful, with uncertainty about ongoing and future actions from the administration, fear of terminations for staff members or their colleagues, and so on,” said Jeremy Berg, PhD, former...

2 weeks ago | cancertherapyadvisor.com | Erin Clancy

Researchers and institutions that rely on funding from the National Institutes of Health (NIH) are contending with ongoing efforts by the Trump administration to cut NIH funding, terminate research grants, and reduce the agency’s workforce.1-31 “From what I understand, the environment within NIH is very stressful, with uncertainty about ongoing and future actions from the administration, fear of terminations for staff members or their colleagues, and so on,” said Jeremy Berg, PhD, former...

1 month ago | hematologyadvisor.com | Erin Clancy

Recent cuts to the federal workforce could negatively impact cancer research and public health for years to come, researchers say. Could ongoing legal battles and the rehiring of some employees prevent or reverse that damage, or are more cuts to the federal workforce on the horizon?

1 month ago | medicalbag.com | Erin Clancy

Recent cuts to the federal workforce could negatively impact cancer research and public health for years to come, researchers say. Could ongoing legal battles and the rehiring of some employees prevent or reverse that damage, or are more cuts to the federal workforce on the horizon?

1 month ago | hematologyadvisor.com | Erin Clancy

Legal battles over the Trump administration’s attempts to freeze federal funding and cut indirect cost payments from the National Institutes of Health (NIH) are playing out in the court system.1-5 Meanwhile, cancer research is being disrupted.6 “[C]ancer centers have struggled to fund new discovery projects in precision therapy, quality of life, and artificial intelligence for diseases such as prostate cancer, pancreatic cancer, and brain tumors,” the American Association of Cancer Research...